TFRC and neoplasm: To mitigate the effects caused by loss of pyoverdine, we also employed the specific ferroptosis inhibitor, ferrostatin, which could also prevent ferroptosis of ΔpvdA mutant‐treated tumor spheroids, where lower levels of ROS and expression of transferrin receptor were observed (Figure S8, Supporting Information).